OAR 309-018-0135

(1) The program shall utilize an entry procedure to ensure the following:
(a) Individuals shall be considered for entry without regard to race, ethnicity, gender, gender identity, gender presentation, sexual orientation, religion, creed, national origin, age, except when program eligibility is restricted to children, adults or older adults, familial status, marital status, source of income, and disability;
(b) Individuals shall receive services in the most timely manner feasible consistent with the presenting circumstances;
(c) The provider may not solely deny entry to individuals who are prescribed medication to treat opioid dependence.
(2) Written informed consent for services shall be obtained from the individual or guardian, if applicable, prior to the start of services. If such consent is not obtained, the reason shall be documented, and further attempts to obtain informed consent shall be made as appropriate.
(3) The provider shall develop and maintain service records and other documentation for each individual that demonstrates the specific services and supports.
(4) The provider shall report the entry of all individuals on the mandated state data system.
(5) In accordance with ORS 179.505 (Disclosure of written accounts by health care services provider), HIPAA and 42 CFR Part 2, an authorization for the release of information shall be obtained for any confidential information concerning the individual being considered for or receiving services.
(6) At the time of entry, the program shall offer to the individual and guardian, if applicable, written program orientation information. The written information shall be in a language understood by the individual and shall include:
(a) A description of individual rights consistent with these rules;
(b) Policies concerning grievances and appeals consistent with these rules, including an example grievance form;
(c) Notice of privacy practices; and
(d) An opportunity to register to vote.
(7) Entry requirements for providers that receive the Substance Abuse Prevention Treatment (SAPT) Block Grant:
(a) Individuals shall be prioritized in the following order:
(A) Women who are pregnant and using substances intravenously;
(B) Women who are pregnant;
(C) Individuals who are using substances intravenously; and
(D) Individuals with dependent children.
(b) Entry of pregnant women shall occur no later than 48 hours from the date of first contact and entry of individuals using substances intravenously shall occur no later than 14 days after the date of first contact. If services are not available within the required timeframes, the provider shall document the reason and provide interim referral and informational services, as defined in these rules, within 48 hours;
(c) Individuals using substances intravenously shall receive interim referrals and information prior to entry to reduce the adverse health effects of substance use, promote the health of the individual, and reduce the risk of transmission of disease. At a minimum, interim referral and informational services shall include:
(A) Counseling and education about blood borne pathogens including Hepatitis, HIV, STDs, and Tuberculosis (TB); the risks of needle and paraphernalia sharing; and the likelihood of transmission to sexual partners and infants;
(B) Counseling and education about steps that can decrease the likelihood of Hepatitis, HIV, STD, and TB transmission;
(C) Referral for Hepatitis, HIV, STD, and TB testing, vaccine, or care services if necessary; and
(D) For pregnant women, counseling on the likelihood of blood borne pathogen transmission as well as the effects of alcohol, tobacco, and other drug use on the fetus and referral for prenatal care.
Last Updated

Jun. 8, 2021

Rule 309-018-0135’s source at or​.us